Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pharma-Bio Serv (PBSV) Return on Equity (2016 - 2025)

Historic Return on Equity for Pharma-Bio Serv (PBSV) over the last 15 years, with Q4 2025 value amounting to 0.01%.

  • Pharma-Bio Serv's Return on Equity rose 500.0% to 0.01% in Q4 2025 from the same period last year, while for Oct 2025 it was 0.01%, marking a year-over-year increase of 500.0%. This contributed to the annual value of 0.01% for FY2025, which is 400.0% up from last year.
  • According to the latest figures from Q4 2025, Pharma-Bio Serv's Return on Equity is 0.01%, which was up 500.0% from 0.01% recorded in Q3 2025.
  • Pharma-Bio Serv's 5-year Return on Equity high stood at 0.13% for Q3 2021, and its period low was 0.25% during Q3 2022.
  • Moreover, its 5-year median value for Return on Equity was 0.0% (2025), whereas its average is 0.0%.
  • Its Return on Equity has fluctuated over the past 5 years, first tumbled by -3800bps in 2022, then soared by 3500bps in 2023.
  • Pharma-Bio Serv's Return on Equity (Quarter) stood at 0.1% in 2021, then soared by 163bps to 0.06% in 2022, then skyrocketed by 32bps to 0.08% in 2023, then crashed by -170bps to 0.06% in 2024, then soared by 84bps to 0.01% in 2025.
  • Its Return on Equity was 0.01% in Q4 2025, compared to 0.01% in Q3 2025 and 0.02% in Q2 2025.